Older adults frequently experience cognitive impairment after recovering from COVID-19, according to three studies reported last week at an Alzheimer’s Association conference. 
 
Researchers from the University of Texas Health Science Center at San Antonio Long School of Medicine and a global SARS-CoV-2 consortium studied nearly 300 older adult Amerindians in Argentina and found more than half experienced persistent forgetfulness three to six months after infection, which was associated with persistent loss of smell. 
 
Another study with the global consortium looked at cognitive impairment in 32 patients previously hospitalized with mild-to-moderate COVID-19 in Greece. Two months after discharge, 56% presented with cognitive decline, predominantly short-term memory impairments, with worse cognitive scores associated with higher age and waist circumference and lower oxygen saturation levels. 
 
In addition, a study of 310 older COVID-19 patients admitted to New York University Langone Health found 158 had neurological symptoms, most commonly confusion due to toxic-metabolic encephalopathy. Patients with TME had higher levels of certain biomarker indicators of brain injury, neuroinflammation and Alzheimer’s disease, the authors said
 

Related News Articles

Headline
Commenting on a forthcoming Centers for Medicare & Medicaid Services’ rule requiring COVID-19 vaccinations for workers in most health care settings…
Chairperson's File
On this episode, I discuss emergency preparedness, caregiver resiliency and health equity — all through the lens of the COVID-19 pandemic — with Fritz Francois…
Headline
The Centers for Medicare & Medicaid Services today announced that the agency will pay for Medicare beneficiaries’ booster doses, without cost sharing…
Headline
AHA today urged the Office of the United States Trade Representative to extend the current Section 301 tariff exemptions for certain medical devices to ensure…
Headline
The Centers for Disease Control and Prevention early Friday morning opted for a broad endorsement of Pfizer COVID-19 vaccine booster shots, issuing interim…
Headline
The AHA today urged the Health Resources and Services Administration to quickly distribute the $17 billion in Phase 4 provider relief funds and $8.5 billion in…